Home  »  Company  »  Natco Pharma Ltd.  »  Quotes  »  Audited Results
Enter the first few characters of Company and click 'Go'

Audited Results of Natco Pharma Ltd. Company

(Rs in Cr.) Mar 31, 2023 Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019
Operating Income 2,351 1,767.80 1,653.50 1,790.20 1,986.30
Manufacturing Expenses 81.90 76.40 59.40 62.40 59.60
Personnel Expenses 425.70 410.10 380 356.10 340.20
Selling Expenses 0 0 0 0 0
Administrative Expenses 431.60 498.20 268.40 367.70 393.70
Expenses Capitalised 0 0 0 0 0
Cost Of Sales 1,506.30 1,554.80 1,235.90 1,212.20 1,169.80
Operating Profit 844.70 213 417.60 578 816.50
Other Recurring Income 85.50 94.60 101.10 123.80 129.80
Adjusted PBDIT 930.20 307.60 518.70 701.80 946.30
Financial Expenses 8.60 13.30 11.30 20.60 18.80
Depreciation 150.90 138.40 115.20 98.10 80.10
Other Write offs 0 0 0 0 0
Adjusted PBT 770.70 155.90 392.20 583.10 847.40
Tax Charges 133.60 16.80 82.70 108.60 180.30
Adjusted PAT 637.10 139.10 309.50 474.50 667.10
Non Recurring Items 1.70 9.80 -0.30 -5.20 0
Other Non Cash adjustments 0 0 0 0 0
Reported Net Profit 637.10 139.10 309.50 474.50 667.10
Equity Dividend 100.40 82.10 113.90 101.20 73
Preference Dividend 0 0 0 0 0
Retained Earnings 3,125.50 2,586.80 2,517.80 2,348.70 2,046.10
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X